Comprehensive Healthcare Systems Inc · TSXV:CHS
Comprehensive Healthcare Systems — Investor Presentation (June 2026)
21 slides from Comprehensive Healthcare Systems's investor presentation, June 2026
Slide 1: Investor Presentation Q2 2026
INVESTOR PRESENTATION Q2 2026
Slide 2: Agenda
Agenda Disclaimer 02 Executive Summary 03 Comprehensive Introduction 04 Growth Drivers 05 Client Pain Point - CHS Unique Solution 06 CHS Business Model 07 Leveraging AI to Transform CHS Benefits Administration 08 CHS Key Clients 09 CHS Market Opportunity 10 Valuation Benchmarking Industry Peers 11 S
Slide 3: Disclaimer
Disclaimer This presentation and all the information contained herein are confidential, proprietary and for the use solely by the prospective investors and their professional advisors and is not for public distribution. By your acceptance of this presentation you and any person reviewing this presen
Slide 4: Executive Summary
Executive Summary CHS is a leading SaaS based technology company that provides a comprehensive, modular software platform, Novus 360, to self-insured employers, unions and their TPAs to manage all aspects of health care and other benefits programs Leading SaaS-based technology firm in Employee Healt
Slide 5: Introduction
Introduction CHS is a leading SaaS based technology company that provides a comprehensive, modular software platform, Novus 360, to self-insured employers, unions and their TPAs to manage all aspects of health care and other benefits programs 1 2 3 4 5 6 In USA, 60% Large These These TPAs and of the
Slide 6: Growth Drivers
6 Growth Drivers Revenue EBITDA 1.0 Organic Growth 2.1 EBITDA Merger & Acquisition REVENUE (In $ M) Adjacent Verticals 2.5 EBITDA ( In $ M) 0.7 0.1 5.3 FY 24 FY 25 (est) FY 26 (est) 3.8 3.9 FY 24 FY 25 (est) FY 26 (est) -0.6 Total EBITDA % of Revenue 3.8 4.6 9.9 Revenue - 1% 10% Targeted Total Signe
Slide 7: Client Pain Points CHS Unique Solution
Client Pain Points CHS Unique Solution Most unionized healthcare Insurance service providers are not automated and suffer from the following pain points ONLY Integrated Solutions Platform Manual & Paper-based process Process Automation & Digitization Complex Compliance Requirements Automated Complia
Slide 8: CHS Business Model
8 CHS Business Model Comprehensive Healthcare Systems (“Comprehensive”) is a SaaS-based technology firm managing Benefits & Retirement Administration. We use our proprietary NOVUS 360 platform, leveraging state-of-the-art data analytics Tools, AI, and other advanced software solutions to deliver a s
Slide 9: Leveraging AI to Transform CHS Benefits Administration
Leveraging AI to Transform CHS 9 Benefits Administration Strategic AI-driven capabilities to modernize the platform, enhancing member experience while driving operational scalability Orkes AI-Native Workflow Engine AI Chatbot NEW Scalable workflow orchestration 24/7 personalized support CHS has depl
Slide 10: CHS Key Clients
10 CHS Key Clients 20+ long-standing client relationships with exceptional retention rates Amalgamated Life Local 804 Funds WAEPA Local 338 H & WF UFCW Local 464A CIR TOP 5 CLIENTS Insurance Co PARTNERS SINCE 2025 2002 2017 2005 2019 2016 CHS revenue model is Subscription fees Per Member Per Month (
Slide 11: CHS Market Opportunity – Benefits Administration Software
CHS Market Opportunity – Benefits Administration Software Union Taft- Self–Insured Others SEGMENT Hartley TPA Employers Pension (Govt., Hospital & Payor) MARKET SIZE 0.50 0.91 – 1.57 0.91 – 1.58 1.32 - 3.08 2.1 ($ B) (2026) (2024 – 2030) (2024 – 2031) (2023 – 2032) (Approx) Regulatory Complexity Dig
Slide 12: Valuation Benchmarking Industry Peers
Valuation Benchmarking Industry Peers In USD Zenith BeneSys, Inc. Bridgeway $3.2B - $4.6 (est.) $0.2B - $0.4B (est.) $0.4B - $0.5B (est.) Zenith Platform provides Benefits Administration and TPA BenefitDriven delivers Benefits Administration and TPA basys and ISSI provide Benefits Administration sof
Slide 13: Share Capitalization
13 Share Capitalization Total Shares Outstanding 29 M Warrants, RSUs and Stock Options Outstanding ~7M Total Fully diluted shares ~ 36 M Market Capitalization ~ USD 17 M % Shares held by insiders, officers, directors, control group and strategic investors - 60% (Approx.) 12
Slide 14: Conclusion: The Opportunity in Investing Today
Conclusion: The Opportunity in Investing Today ▪ Professional Management, Restructuring of Operations leading to profitability ▪ Business poised for aggressive Growth, have just concluded a game-changing 5 Year multi-million contract with Amalgamated Life Insurance Co and with other large prospects
Slide 15: Statutory Rights of Action
Statutory Rights of Action In certain circumstances, purchasers resident in certain provinces of Canada, are provided with a remedy for rescission or damages, or both, in addition to any other right they may have at law, where a presentation and any amendment to it contains a misrepresentation. Wher
Slide 16: Thank You / Contact Us
THANK YOU Contact Us https://www.comphealthcare.com/ Chris Cosgrove chris.cosgrove@comphealthcare.com +1-201-694-2926 Vikas Ranjan vikas.ranjan@principlecp.com vikas.ranjan@comphealthcare.com +1-416-605-7024 15
Slide 17: Annexure
oO NN , 15 Ee WM tc )<
Slide 18: CHS Leadership Team
CHS Leadership Chris Cosgrove Chief Executive Officer Brings 30+ years of healthcare leadership, driving growth, ROI, and client success Peter Kapoor Executive Director Drives global growth, market expansion, & strategic execution with proven commercial Mariam Cather Strategy Officer Leads healthcar
Slide 19: Board of Directors
Board of Directors Chris Cosgrove Amit Dutta Vikas Ranjan Chief Executive Officer & President Director Director Chris, CEO of Comprehensive Healthcare Amit is a partner at Hunch Ventures and the Co-founder of Gravitas Group of Systems, brings 30+ years of healthcare managing director/co-founder of H
Slide 20: Transforming CHS Business to a Market Leader with strong profitability
Transforming CHS Business to a Market Leader with strong profitability Leveraging the US Healthcare services opportunity Market poised for explosive growth, CHS Addressable Market USD 4B to 6B AI, digital health, and biotech are fueling unprecedented innovation and investor interest in US healthcare
Slide 21: Competitive Market Analysis
Competitive Market Analysis 21 Benefits Pricing Medical Financial Pharmacy Benefits Administration TPA SaaS Transparency Management Recovery Management Financial Recovery & Pharmacy Benefits provided in collaboration with Affiliated partners DISCLAIMER: 19 This competitive market analysis is based o
Comprehensive Healthcare Systems — Investor Presentation (June 2026) on 6ix